BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6253328)

  • 21. Chick bone collagenase inhibitor and latency of collagenase.
    Sakamoto S; Sakamoto M; Matsumoto A; Nagayama M; Glimcher MJ
    Biochem Biophys Res Commun; 1981 Nov; 103(1):339-46. PubMed ID: 6274345
    [No Abstract]   [Full Text] [Related]  

  • 22. [Collagenase of human leukocytes. Its characteristics, function and regulatory mechanisms].
    Grabowska-Bochenek R; Drózdz M
    Postepy Hig Med Dosw; 1991; 45(3-4):199-214. PubMed ID: 1658760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Collagenase activity in polymorphonuclear granulocytes an synovial fluid in patients with progressive chronic polyarthritis (proceedings)].
    Menzel J; Youngchaiyud U; Smolen JS; Endler AT; Kojer M; Frank O; Eberl R; Chlud K; Steffen C
    Acta Med Austriaca Suppl; 1976; 3():200. PubMed ID: 197766
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of lectin affinity chromatography for the purification of collagenase from human polymorphonuclear leukocytes.
    Callaway JE; Garcia JA; Hersh CL; Yeh RK; Gilmore-Hebert M
    Biochemistry; 1986 Aug; 25(17):4757-62. PubMed ID: 3021203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collagenase inhibitors: rationale for their use in treating corneal ulceration.
    Berman
    Int Ophthalmol Clin; 1975; 15(4):49-66. PubMed ID: 57940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of human polymorphonuclear leukocyte collagenase on sub-component C1q of the first component of human complement.
    Fletcher DS; Williams HR; Lin TY
    Biochim Biophys Acta; 1978 May; 540(2):270-7. PubMed ID: 207353
    [No Abstract]   [Full Text] [Related]  

  • 27. A novel inhibitor of mammalian collagenase.
    Clark DE; Wei P; Grant NH
    Life Sci; 1985 Aug; 37(6):575-8. PubMed ID: 2991688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of collagenase activity in eosinophil and neutrophil fractions from rat peritoneal exudates.
    Bassett EG; Baker JR; BAKER PA; MYERS DB
    Aust J Exp Biol Med Sci; 1976 Oct; 54(5):459-65. PubMed ID: 190990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The identification, purification and characterisation of an inhibitor of collagenase (20K) produced by neoplastic epithelial cells.
    Whitelock JM; O'Grady RL; Gibbins JR
    Biochim Biophys Acta; 1991 Jan; 1073(1):107-13. PubMed ID: 1846753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Origin of cervical collagenase during parturition.
    Osmers R; Rath W; Adelmann-Grill BC; Fittkow C; Kuloczik M; Szeverényi M; Tschesche H; Kuhn W
    Am J Obstet Gynecol; 1992 May; 166(5):1455-60. PubMed ID: 1317677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Collagenase inhibitors].
    François J; Cambie E
    Annee Ther Clin Ophtalmol; 1976; 27():197-215. PubMed ID: 209726
    [No Abstract]   [Full Text] [Related]  

  • 32. Gold(I) compounds and human neutrophil collagenase.
    Sorsa T; Konttinen YT; Lauhio A; Saari H; Suomalainen K; Lindy S
    J Rheumatol; 1989 Jul; 16(7):1009-10. PubMed ID: 2549240
    [No Abstract]   [Full Text] [Related]  

  • 33. Collagenase and neutral protease activities in cultures of rabbit VX-2 carcinoma.
    Dabbous MK; Roberts AN; Brinkley B
    Cancer Res; 1977 Oct; 37(10):3537-44. PubMed ID: 198116
    [No Abstract]   [Full Text] [Related]  

  • 34. A latent collagenase released by bone and skin explants in culture.
    Vaes G
    Biochem J; 1971 Jul; 123(4):23P-24P. PubMed ID: 4331320
    [No Abstract]   [Full Text] [Related]  

  • 35. Evidence that latent collagenases are enzyme-inhibitor complexes.
    Sellers A; Cartwright E; Murphy G; Reynolds JJ
    Biochem J; 1977 May; 163(2):303-7. PubMed ID: 194584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential.
    Suomalainen K; Sorsa T; Golub LM; Ramamurthy N; Lee HM; Uitto VJ; Saari H; Konttinen YT
    Antimicrob Agents Chemother; 1992 Jan; 36(1):227-9. PubMed ID: 1317148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collagenolytic activity from circulating polymorphonuclear leucocytes of patients with asbestosis.
    Lemaire I; Grondin C; Bégin R
    Experientia; 1984 Jul; 40(7):736-7. PubMed ID: 6086383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preferential binding of collagenase to alpha 2-macroglobulin in the presence of the tissue inhibitor of metalloproteinases.
    Cawston TE; Mercer E
    FEBS Lett; 1986 Dec; 209(1):9-12. PubMed ID: 2433154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of human plasma C1-inhibitor by human PMN leucocyte matrix metalloproteinases.
    Knäuper V; Triebel S; Reinke H; Tschesche H
    FEBS Lett; 1991 Sep; 290(1-2):99-102. PubMed ID: 1655539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Latent collagenase of rheumatoid synovial fluid is not of granulocytic origin.
    Wize J; Wierzchowska E; Wojtecka-Lukasik E; Garwolińska H; Maśliński S
    Biochim Biophys Acta; 1984 Oct; 801(3):360-4. PubMed ID: 6091771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.